Literature DB >> 25573974

Complications in children and adolescents with Chuvash polycythemia.

Adelina I Sergueeva1, Galina Y Miasnikova2, Lydia A Polyakova2, Mehdi Nouraie3, Josef T Prchal4, Victor R Gordeuk5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25573974      PMCID： PMC4287647          DOI： 10.1182/blood-2014-10-604660

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia.

Authors:  Sonny O Ang; Hua Chen; Kiichi Hirota; Victor R Gordeuk; Jaroslav Jelinek; Yongli Guan; Enli Liu; Adelina I Sergueeva; Galina Y Miasnikova; David Mole; Patrick H Maxwell; David W Stockton; Gregg L Semenza; Josef T Prchal
Journal:  Nat Genet       Date:  2002-11-04       Impact factor: 38.330

2.  [Familial erythrocytosis among the residents of the Chuvash ASSR].

Authors:  L A Poliakova
Journal:  Probl Gematol Pereliv Krovi       Date:  1974-10

Review 3.  Vascular complications in Chuvash polycythemia.

Authors:  Victor R Gordeuk; Josef T Prchal
Journal:  Semin Thromb Hemost       Date:  2006-04       Impact factor: 4.180

4.  Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia).

Authors:  Craig A Sable; Zakari Y Aliyu; Niti Dham; Mehdi Nouraie; Vandana Sachdev; Stanislav Sidenko; Galina Y Miasnikova; Lydia A Polyakova; Adelina I Sergueeva; Daniel J Okhotin; Vladimir Bushuev; Alan T Remaley; Xiaomei Niu; Oswaldo L Castro; Mark T Gladwin; Gregory J Kato; Josef T Prchal; Victor R Gordeuk
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

5.  Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors.

Authors:  Victor R Gordeuk; Adelina I Sergueeva; Galina Y Miasnikova; Daniel Okhotin; Yaroslav Voloshin; Peter L Choyke; John A Butman; Katerina Jedlickova; Josef T Prchal; Lydia A Polyakova
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

6.  Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia.

Authors:  Ryan C Russell; Roxana I Sufan; Bing Zhou; Pardeep Heir; Severa Bunda; Stephanie S Sybingco; Samantha N Greer; Olga Roche; Samuel A Heathcote; Vinca W K Chow; Lukasz M Boba; Terri D Richmond; Michele M Hickey; Dwayne L Barber; David A Cheresh; M Celeste Simon; Meredith S Irwin; William Y Kim; Michael Ohh
Journal:  Nat Med       Date:  2011-06-19       Impact factor: 53.440
  6 in total
  7 in total

1.  Prospective study of thrombosis and thrombospondin-1 expression in Chuvash polycythemia.

Authors:  Adelina Sergueeva; Galina Miasnikova; Binal N Shah; Jihyun Song; Ekaterina Lisina; Daniel J Okhotin; Mehdi Nouraie; Sergei Nekhai; Tatiana Ammosova; Xiao Mei Niu; Josef T Prchal; Xu Zhang; Victor R Gordeuk
Journal:  Haematologica       Date:  2017-01-19       Impact factor: 9.941

Review 2.  Genetic Background of Congenital Erythrocytosis.

Authors:  Mary Frances McMullin
Journal:  Genes (Basel)       Date:  2021-07-28       Impact factor: 4.096

3.  Clinical Improvement with JAK2 Inhibition in Chuvash Polycythemia.

Authors:  Amy W Zhou; Eric M Knoche; Elizabeth K Engle; Makiko Ban-Hoefen; Charu Kaiwar; Stephen T Oh
Journal:  N Engl J Med       Date:  2016-08-04       Impact factor: 91.245

4.  Thrombotic risk in congenital erythrocytosis due to up-regulated hypoxia sensing is not associated with elevated hematocrit.

Authors:  Victor R Gordeuk; Galina Y Miasnikova; Adelina I Sergueeva; Felipe R Lorenzo; Xu Zhang; Jihyun Song; David W Stockton; Josef T Prchal
Journal:  Haematologica       Date:  2019-07-09       Impact factor: 9.941

5.  Therapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases.

Authors:  Manik C Ghosh; De-Liang Zhang; Wade H Ollivierre; Audrey Noguchi; Danielle A Springer; W Marston Linehan; Tracey A Rouault
Journal:  Blood       Date:  2021-05-06       Impact factor: 25.476

Review 6.  Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis.

Authors:  Victor R Gordeuk; Nigel S Key; Josef T Prchal
Journal:  Haematologica       Date:  2019-03-14       Impact factor: 9.941

7.  HIF2A gain-of-function mutation modulates the stiffness of smooth muscle cells and compromises vascular mechanics.

Authors:  Xin Yi Chan; Eugenia Volkova; Joon Eoh; Rebecca Black; Lilly Fang; Rayyan Gorashi; Jihyun Song; Jing Wang; Morgan B Elliott; Sebastian F Barreto-Ortiz; James Chen; Brian L Lin; Lakshmi Santhanam; Linzhao Cheng; Frank S Lee; Josef T Prchal; Sharon Gerecht
Journal:  iScience       Date:  2021-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.